You are here
Articles
Posted on Saturday, February 20, 2016 - 5:40pm
Treatment with the BCR-ABL tyrosine kinase inhibitors (TKIs) dasatinib, nilotinib, and ponatinib was associated with increased risk for vascular occlusive events in patients with chronic myeloid leukemia (CML) compared...
Posted on Saturday, February 20, 2016 - 5:30pm
Posted on Thursday, February 18, 2016 - 2:45pm
University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today — an inability to get patients off treatment.
Posted on Thursday, February 11, 2016 - 5:45pm
Five-year results of the randomised phase III ENESTnd trial show a positive risk-benefit profile for nilotinib in patients with chronic myeloid leukaemia (CML) in chronic phase (CP), as compared to imatinib....
Posted on Wednesday, January 6, 2016 - 8:00pm
Abstract
Posted on Tuesday, December 22, 2015 - 3:03pm
As a member of the Blood Cancers Alliance (BCA), an informal coalition of charities representing the blood cancer community, Myeloma UK wrote an open...
Posted on Monday, December 21, 2015 - 5:56pm
The International CML Foundation (iCMLf) is a Foundation established by a group of leading hematologists with a strong interest in CML.
Posted on Thursday, December 17, 2015 - 1:56pm
Posted on Wednesday, December 9, 2015 - 11:54am
Chronic Myeloid Leukemia: TherapyProgram: Oral and Poster AbstractsType: Oral
Posted on Saturday, November 7, 2015 - 1:54pm
M Talpaz1, R Hehlmann2, A Quintás-Cardama3, J Mercer1 and J Cortes3
Posted on Thursday, November 5, 2015 - 11:58am
Rousselot et al1 recently reported on the According to Stop Imatinib (A-STIM) study evaluating the persistence of major molecular response (MMR) in patients with chronic-phase chronic myeloid leukemia (CP CML) who had...
Posted on Tuesday, October 13, 2015 - 1:08pm
Merrill J Egorin,1,2,3 Dhvani D Shah,1 Susan M Christner,1 Mara A Yerk,4 Kristin A Komazec,4 Leonard R Appleman,2 Robert L Redner,2 Brian M Miller,5 and Jan H Beumer1,6
AbstractAIMS
Posted on Wednesday, October 7, 2015 - 9:58am
I said I would report back to our members on the NHS England meeting, held on the 7th September and on any subsequent activity taken by the coalitions of the patient organisations CML Support Group are members of.
- ‹ previous
- 8 of 33
- next ›